Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05326750

Non-invasive Neurostimulation as a Tool for Diagnostics and Management for Neurodegenerative Diseases

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
200 (estimated)
Sponsor
Kuopio University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Double blinded, sham-controlled, randomized trial on repeated transcranial alternating current brain stimulation (tACS) in neurodegenerative diseases. The investigators will evaluate whether a 4-times daily repeated stimulation with gamma tACS on the posterior parietal cortex can improve symptoms in patients with neurodegenerative diseases, including dementia with Lewy Bodies, Alzheimer's disease, idiopathic normal pressure hydrocephalus and Frontotemporal dementia.

Detailed description

Double blinded, sham-controlled, randomized trial on repeated transcranial alternating current brain stimulation (tACS) in neurodegenerative diseases. The investigators will evaluate whether a 4-times daily repeated stimulation with gamma tACS on the posterior parietal cortex can improve symptoms in patients with neurodegenerative diseases, including dementia with Lewy Bodies, Alzheimer's disease, idiopathic normal pressure hydrocephalus and Frontotemporal dementia.

Conditions

Interventions

TypeNameDescription
DEVICEGamma tACS (40 Hz) over the superior parietal cortexSingle session of gamma tACS (40 Hz) over the superior parietal cortex

Timeline

Start date
2022-11-21
Primary completion
2032-07-01
Completion
2032-07-01
First posted
2022-04-14
Last updated
2025-09-03

Locations

1 site across 1 country: Finland

Source: ClinicalTrials.gov record NCT05326750. Inclusion in this directory is not an endorsement.